Autism is a spectrum. This metaphor is a helpful way to explain why autism looks and feels so varied across different people. Since 2013 it’s been baked into the name of the diagnosis itself, autism ...
Each spring, amateur astronomers attempt the ultimate stargazing challenge—an overnight quest to spot every galaxy, nebula, and star cluster in Charles Messier’s famous catalog. Photographer Alan Dyer ...
Great River Health is taking a major step forward in enhancing the patient experience by transitioning to Epic, the nation’s leading electronic health record (EHR) system. Beginning June 6, patients ...
On average, participants improved by 25 letters on a standard eye chart when using the implant. This improvement is equal to about five lines on the chart. In addition, more than 80 percent of ...
For people with advanced vision loss, losing the ability to read is often one of the hardest changes to accept. Everyday tasks – such as checking a phone number, reading a label, or recognizing a ...
Susvimo is an FDA-approved eye implant for diabetic macular edema that can be refilled every six months instead of requiring monthly injections. Diabetic macular edema affects about 5% to 7% of people ...
Arguably no sport has a closer relationship with the stats that chronicle its every play. Standard stats are widely used by those who play fantasy baseball. A typical fantasy baseball league will use ...
The African Export-Import Bank (Afreximbank) has reinforced its position as a powerhouse in African capital markets, securing top spots as mandated lead arranger and bookrunner in the 2025 Bloomberg ...
A tiny wireless retinal implant has helped restore central vision in people with advanced age-related macular degeneration (AMD), according to results published in the New England Journal of Medicine.
Welcome to Nationals Park, the home of the Washington Nationals, and located in the Navy Yard neighborhood of the nation’s capital. Washington Nationals Established: 2005 (relocated from Montreal, ...
A tiny wireless implant is giving new hope to people blinded by advanced age-related macular degeneration. In a major international clinical trial, more than 80% of participants regained meaningful ...